Patent Assignment
Reel/Frame 023120/0064
Assignment of Assignor's Interest
Recorded: 2009-08-19
Pages: 6
Assignor
ALNYLAM EUROPE AG
Executed: 2009-08-05
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties
(4)
Double-Stranded Rna (Dsrna) and Method of Use for Inhibiting Expression of the Aml-1/MTG8 Fusion Gene
Compositions and Methods for Inhibiting Expression of a Mutant Gene
Lipophilic derivatives of double-stranded ribonucleic acid
Application:
10/543,048 →
Publication:
US 2006/0178324
Double-Stranded Rna (Dsrna) and Method of Use for Inhibiting Expression of a Fusion Gene
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 6, 2003
From: KREUTZER, ROLAND; LIMMER, STEFAN; JOHN, MATTHIAS
To: RIBOPHARMA AG
Reel/Frame 014828/0588 →
Assignment of Assignor's Interest
Jun 24, 2003
From: HEIDENREICH, OLAF; VORNLOCHER, HANS-PETER; KREUTZER, ROLAND; LIMMER, STEFAN
To: RIBOPHARMA AG
Reel/Frame 014914/0536 →
Change of Name
Jun 22, 2004
From: RIBOPHARMA AG
To: ALNYLAM EUROPE AG
Reel/Frame 015488/0614 →
Assignment of Assignor's Interest
Jan 26, 2006
From: HADWIGER, PHILIPP; JOHN, MATTHIAS; LORENZ, CHRISTINA; VORNLOCHER, HANS-PETER
To: ALNYLAM EUROPE AG
Reel/Frame 017216/0009 →
Assignment of Assignor's Interest
Mar 14, 2007
From: RIBOPHARMA AG
To: ALNYLAM EUROPE AG
Reel/Frame 019013/0954 →
Assignment of Assignor's Interest
Mar 14, 2007
From: HEIDENREICH, OLAF; VORNLOCHER, HANS-PETER; KREUTZER, ROLAND; LIMMER, STEFAN
To: RIBOPHARMA AG
Reel/Frame 019013/0328 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →